Nanoparticle Synthesis Process Facilitates Chiral Separations

Sanofi will use this investment to increase its antibody bioproduction at its site in Lyon Gerland, France.

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.

Located in German, Italy, and Lithuania, the new European facilities will specialize in drug discovery and R&D services.

In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.

Financing from OrbiMed, Novo Holdings, Jeito Capital, and others will enable Alentis Therapeutics to advance its pipeline of Claudin-1-targeted ADCs for treating solid tumors.

Frontier Scientific Solutions has unveiled plans to use a $1.5 billion commitment from a major investor to create a global free trade zone gateway to facilitate the life sciences supply chain using Wilmington International Airport in North Carolina.